Expert panel recommends Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds - Report - Android - Apps and news for India

Expert panel recommends Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds - Report - Android

«««««

»»»»»

New Delhi, May 12: Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. The trial will take place in 525 subjects

12/05/2021 01:23 AM

oneindia.in

«««««

»»»»»

Rains predicted in Delhi - MeT

12/05/2021 08:15 AM

Ventilators to be alternate to HFNO in Karnataka

12/05/2021 08:15 AM

International Nurses Day 2021 - A day to celebrate COVID-19 frontline heroes who tirelessly serve us

12/05/2021 08:15 AM

Realme C20A announced with MediaTek Helio G35 SoC, 5000mAh battery

12/05/2021 08:15 AM

Coronavirus vaccine - India administers over 175 million COVID-19 vaccine doses till now

12/05/2021 08:15 AM

YouTube Shorts Fund Announced, to Distribute $100 Million Among Creators

12/05/2021 08:15 AM

Redmi Note 10S launch set for May 13 - Specs, expected price in India, livestream link, more

12/05/2021 08:15 AM

Galaxy Z Fold 3 camera specs leak suggest in-display camera

12/05/2021 02:26 AM